世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

無菌試験市場:製品毎、試験毎、用途毎 - 2021年までの世界市場予測

Sterility Testing Market by Product (Instruments, Services, Kits and Reagents), Test (Membrane Filtration Sterility Testing, Direct Inoculation Sterility Testing), Application (Pharmaceutical & Biotechnology, Medical Devices) - Global Forecasts to 2021

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2017年3月US$5,650
シングルユーザライセンス
126 102

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の無菌試験市場に関する調査レポートです。

The sterility testing market is expected to reach USD 941.0 million by 2021 from USD 528.0 million in 2016, at a CAGR of 12.3%. The major drivers for the market include growth in the pharmaceutical and biotechnology industries, increase in the number of new drug launches, and increasing R&D in life science research. Over the years, the number of drug approvals in North American has increased. In 2015, the FDA’s Center for Drug Evaluation and Research (CDER) approved 45 novel drugs as new molecular entities (NMEs) under New Drug Applications (NDAs) or as new therapeutic biologics under Biologics License Applications (BLAs); as opposed to this, only 22 novel drugs were approved in 2006. The increasing number of drug approvals will boost the sterility testing market.

According to OECD estimates, in 2015, the total number of biotechnology companies in the U.S. was 11,367. Owing to the rise in the number of biotechnology companies, biopharmaceutical production has increased globally. Sterility testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the sterility testing market.

On the basis of product, the sterility testing market is segmented into kits and reagents, instruments, and services. The kits and reagents segment is projected to witness the highest growth in this market. The large share of the kits and reagents segment can be attributed to the requirement of the repeat purchase of these products, coupled with the increasing preference for kit-based testing.

On the basis of test, the sterility testing market is segmented into membrane filtration, direct inoculation, and other sterility tests. The membrane filtration segment is projected to witness the highest growth in this market due to new product launches and growth in the pharmaceutical and biotechnology industries.

On the basis of application, sterility testing market is segmented into pharmaceutical and biological manufacturing, medical devices manufacturing, and others applications. The pharmaceutical and biological manufacturing segment is projected to witness the highest growth in this market due to rapid growth in the pharma and biotech industries.
Geographically, the sterility testing market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The Asian market will witness the highest growth during the forecast period, primarily due to the increasing expenditure on life science research in the region and growing trend of pharmaceutical outsourcing to Asian countries like India and China.

The key players in the sterility testing market include Merck KGaA (Germany), Charles River Laboratories International, Inc. (U.S.), bioM-rieux SA (France), SGS S.A. (Switzerland), Sartorius AG (Germany), WuXi AppTec (China), and Thermo Fisher Scientific, Inc. (U.S.).

ResearchCoverage

In addition to comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles in this report comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the sterility testing market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of the top players in the sterility testing market. The report analyses the in sterility testing market by product, test, and application
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the sterility testing market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the sterility testing market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various sterility testing products across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the sterility testing market



目次

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.3 MARKET SHARE ESTIMATION 22
2.3.1 KEY DATA FROM SECONDARY SOURCES 22
2.3.2 KEY DATA FROM PRIMARY SOURCES 23
2.3.3 ASSUMPTIONS FOR THE STUDY 23

3 EXECUTIVE SUMMARY 24

4 PREMIUM INSIGHTS 28
4.1 SIGNIFICANT OPPORTUNITIES IN THE STERILITY TESTING MARKET 28
4.2 GEOGRAPHIC ANALYSIS: STERILITY TESTING MARKET, BY PRODUCT (2016) 29
4.3 GEOGRAPHIC SNAPSHOT OF THE STERILITY TESTING MARKET 30

5 MARKET OVERVIEW 31
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Growth of pharmaceutical & biotechnology companies 33
5.2.1.2 Increasing number of drug launches 33
5.2.1.3 Government support for pharmaceutical and biotechnology industries 33
5.2.1.4 Increasing R&D investments in life sciences 34
5.2.2 RESTRAINTS 34
5.2.2.1 High degree of consolidation, a major barrier for new market entrants 34
5.2.2.2 Stringent regulatory frameworks and time-consuming approval processes 34
5.2.3 OPPORTUNITIES 35
5.2.3.1 Emerging Markets 35
5.2.3.2 Increasing pharmaceutical outsourcing 35
5.2.4 CHALLENGE 35
5.2.4.1 Shortage of skilled professionals 35
5.3 PORTER’S FIVE FORCES ANALYSIS 36
5.4 SUPPLY CHAIN ANALYSIS 37

6 STERILITY TESTING MARKET, BY PRODUCT 38
6.1 INTRODUCTION 39
6.2 KITS & REAGENTS 40
6.3 SERVICES 40
6.4 INSTRUMENTS 41

7 STERILITY TESTING MARKET, BY TEST 42
7.1 INTRODUCTION 43
7.2 MEMBRANE FILTRATION 44
7.3 DIRECT INOCULATION 45
7.4 OTHER TESTS 46

8 STERILITY TESTING MARKET, BY APPLICATION 47
8.1 INTRODUCTION 48
8.2 PHARMACEUTICAL AND BIOLOGICAL MANUFACTURING 49
8.3 MEDICAL DEVICE MANUFACTURING 50
8.4 OTHER APPLICATIONS 51

9 STERILITY TESTING MARKET, BY REGION 52
9.1 INTRODUCTION 53
9.2 NORTH AMERICA 55
9.2.1 U.S. 58
9.2.2 CANADA 60
9.3 EUROPE 62
9.3.1 GERMANY 65
9.3.2 U.K. 66
9.3.3 FRANCE 68
9.3.4 ITALY 69
9.3.5 SPAIN 70
9.3.6 REST OF EUROPE (ROE) 71
9.4 ASIA 73
9.4.1 CHINA 76
9.4.2 JAPAN 78
9.4.3 INDIA 79
9.4.4 REST OF ASIA 80
9.5 REST OF THE WORLD 82
9.5.1 SOUTH AMERICA, CENTRAL AMERICA, AND THE CARIBBEAN 83
9.5.2 PACIFIC AND OCEANIA 85
9.5.3 AFRICA 86

10 COMPETITIVE LANDSCAPE 88
10.1 OVERVIEW 88
10.2 STRATEGIC OVERVIEW 88
10.3 MARKET SHARE ANALYSIS 89
10.4 COMPETITIVE SITUATION AND TRENDS 90
10.4.1 EXPANSIONS 91
10.4.2 MERGERS & ACQUISITIONS 92
10.4.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 93
10.4.4 PRODUCT LAUNCHES 94

11 COMPANY PROFILES 95
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 INTRODUCTION 95
11.2 MERCK KGAA 96
11.3 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 99
11.4 BIOM-RIEUX SA 101
11.5 SGS S.A. 103
11.6 DANAHER CORPORATION 105
11.7 NELSON LABORATORIES 107
11.8 PACIFIC BIOLABS 108
11.9 SARTORIUS AG 109
11.10 THERMO FISHER SCIENTIFIC INC. 111
11.11 TOXIKON CORPORATION 113
11.12 WUXI APPTEC 114
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12 APPENDIX 116
12.1 INSIGHTS OF INDUSTRY EXPERTS 116
12.2 DISCUSSION GUIDE 117
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 119
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 121
12.5 AVAILABLE CUSTOMIZATIONS 122
12.6 RELATED REPORTS 123
12.7 AUTHOR DETAILS 124


LIST OF TABLES

TABLE 1 STERILITY TESTING MARKET SUMMARY 24
TABLE 2 STERILITY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 39
TABLE 3 STERILITY TESTING KITS & REAGENTS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 40
TABLE 4 STERILITY TESTING SERVICES MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 41
TABLE 5 STERILITY TESTING INSTRUMENTS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 41
TABLE 6 STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 43
TABLE 7 STERILITY TESTING MARKET SIZE FOR MEMBRANE FILTRATION,
BY REGION, 2014-2021 (USD MILLION) 44
TABLE 8 STERILITY TESTING MARKET SIZE FOR DIRECT INOCULATION,
BY REGION, 2014-2021 (USD MILLION) 45
TABLE 9 STERILITY TESTING MARKET SIZE FOR OTHER TESTS, BY REGION,
2014-2021 (USD MILLION) 46
TABLE 10 STERILITY TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 48
TABLE 11 STERILITY TESTING MARKET SIZE FOR PHARMACEUTICAL AND BIOLOGICAL MANUFACTURING, BY REGION, 2014-2021 (USD MILLION) 49
TABLE 12 STERILITY TESTING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURING,
BY REGION, 2014-2021 (USD MILLION) 50
TABLE 13 STERILITY TESTING MARKET SIZE FOR OTHER APPLICATIONS, BY REGION,
2014-2021 (USD MILLION) 51
TABLE 14 STERILITY TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 53
TABLE 15 NORTH AMERICA: STERILITY TESTING MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 57
TABLE 16 NORTH AMERICA: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 57
TABLE 17 NORTH AMERICA: STERILITY TESTING MARKET SIZE, BY TEST,
2014-2021 (USD MILLION) 57
TABLE 18 NORTH AMERICA: STERILITY TESTING MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 58
TABLE 19 U.S.: STERILITY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 59
TABLE 20 U.S.: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 59
TABLE 21 U.S.: STERILITY TESTING MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 59
TABLE 22 CANADA: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 60
TABLE 23 CANADA: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 61
TABLE 24 CANADA: STERILITY TESTING MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 61
TABLE 25 EUROPE: STERILITY TESTING MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 63
TABLE 26 EUROPE: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 64
TABLE 27 EUROPE: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 64
TABLE 28 EUROPE: STERILITY TESTING MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 64
TABLE 29 GERMANY: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 65
TABLE 30 GERMANY: STERILITY TESTING MARKET SIZE, BY TEST,
2014-2021 (USD MILLION) 66
TABLE 31 U.K.: STERILITY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 67
TABLE 32 U.K.: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 67
TABLE 33 FRANCE: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 68
TABLE 34 FRANCE: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 69
TABLE 35 ITALY: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 69
TABLE 36 ITALY: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 70
TABLE 37 SPAIN: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 71
TABLE 38 SPAIN: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 71
TABLE 39 ROE: STERILITY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 72
TABLE 40 ROE: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 72
TABLE 41 ASIA: STERILITY TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 75
TABLE 42 ASIA: STERILITY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 75
TABLE 43 ASIA: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 75
TABLE 44 ASIA: STERILITY TESTING MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 76
TABLE 45 CHINA: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 77
TABLE 46 CHINA: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 77
TABLE 47 JAPAN: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 78
TABLE 48 JAPAN: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 79
TABLE 49 INDIA: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 80
TABLE 50 INDIA: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 80
TABLE 51 REST OF ASIA: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 81
TABLE 52 REST OF ASIA: STERILITY TESTING MARKET SIZE, BY TEST,
2014-2021 (USD MILLION) 81
TABLE 53 ROW: STERILITY TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 82
TABLE 54 ROW: STERILITY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 82
TABLE 55 ROW: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 83
TABLE 56 ROW: STERILITY TESTING MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 83
TABLE 57 SOUTH AMERICA, CENTRAL AMERICA, & THE CARIBBEAN: STERILITY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 84
TABLE 58 SOUTH AMERICA, CENTRAL AMERICA, & THE CARIBBEAN: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 84
TABLE 59 PACIFIC AND OCEANIA: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 85
TABLE 60 PACIFIC AND OCEANIA: STERILITY TESTING MARKET SIZE, BY TEST,
2014-2021 (USD MILLION) 85
TABLE 61 AFRICA: STERILITY TESTING MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 86
TABLE 62 AFRICA: STERILITY TESTING MARKET SIZE, BY TEST, 2014-2021 (USD MILLION) 87
TABLE 63 MARKET DEVELOPMENTS, 2013-2016 90
TABLE 64 EXPANSIONS, 2013-2016 91
TABLE 65 MERGERS & ACQUISITIONS, 2013-2016 92
TABLE 66 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016 93
TABLE 67 PRODUCT LAUNCHES, 2013-2016 94


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 19
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 19
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 20
FIGURE 5 DATA TRIANGULATION METHODOLOGY 21
FIGURE 6 STERILITY TESTING MARKET SIZE, BY PRODUCT AND SERVICE,
2016 VS. 2021 (USD MILLION) 25
FIGURE 7 STERILITY TESTING MARKET SIZE, BY TEST, 2016 VS. 2021 (USD MILLION) 25
FIGURE 8 STERILITY TESTING MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION) 26
FIGURE 9 STERILITY TESTING MARKET SIZE, BY REGION, 2016 VS. 2021 (USD MILLION) 26
FIGURE 10 STERILITY TESTING MARKET TO REGISTER A DOUBLE-DIGIT GROWTH RATE IN THE FORECAST PERIOD 28
FIGURE 11 KITS AND REAGENTS ACCOUNTED FOR THE LARGEST SHARE OF THE STERILITY TESTING MARKET IN 2016 29
FIGURE 12 ASIA TO REGISTER THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 30
FIGURE 13 STERILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 32
FIGURE 14 STERILITY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 36
FIGURE 15 STERILITY TESTING MARKET: SUPPLY CHAIN ANALYSIS 37
FIGURE 16 KITS AND REAGENTS SEGMENT TO DOMINATE THE STERILITY TESTING PRODUCTS MARKET DURING THE FORECAST PERIOD 39
FIGURE 17 MEMBRANE FILTRATION TO DOMINATE THE STERILITY TESTING MARKET, BY TEST, DURING THE FORECAST PERIOD 43
FIGURE 18 PHARMACEUTICAL AND BIOLOGICAL MANUFACTURING SEGMENT TO DOMINATE THE STERILITY TESTING APPLICATIONS MARKET 48
FIGURE 19 NORTH AMERICA TO DOMINATE THE STERILITY TESTING MARKET IN 2016 53
FIGURE 20 ASIAN MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2016-2021) 54
FIGURE 21 U.S. TO WITNESS HIGHEST GROWTH IN THE NORTH AMERICAN STERILITY TESTING MARKET DURING THE FORECAST PERIOD (2016-2021) 55
FIGURE 22 NORTH AMERICA: STERILITY TESTING MARKET SNAPSHOT 56
FIGURE 23 EUROPE: STERILITY TESTING MARKET, BY COUNTRY
(MARKET SIZE AND GROWTH RATE) 63
FIGURE 24 ASIA: STERILITY TESTING MARKET SIZE, BY COUNTRY, 2016, (MARKET SIZE AND GROWTH RATE) 73
FIGURE 25 ASIA: STERILITY TESTING MARKET SNAPSHOT 74
FIGURE 26 KEY DEVELOPMENTS IN THE STERILITY TESTING MARKET, 2013-2016 88
FIGURE 27 GLOBAL STERILITY TESTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 89
FIGURE 28 GEOGRAPHIC REVENUE MIX OF TOP 4 MARKET PLAYERS 95
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2015) 96
FIGURE 30 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2015) 99
FIGURE 31 BIOM-RIEUX SA: COMPANY SNAPSHOT (2015) 101
FIGURE 32 SGS S.A.: COMPANY SNAPSHOT (2015) 103
FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2015) 105
FIGURE 34 SARTORIUS AG: COMPANY SNAPSHOT (2015) 109
FIGURE 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2015) 111
 

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

Sterility Testing Market worth 941.0 Million USD by 2021


March 20, 2017

The report "Sterility Testing Market by Product (Instruments, Services, Kits and Reagents), Test (Membrane Filtration Sterility Testing, Direct Inoculation Sterility Testing), Application (Pharmaceutical & Biotechnology, Medical Devices) - Global Forecasts to 2021", This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the sterility testing market, along with revenue estimates & forecasts and market share analysis.

The global sterility testing market is expected to reach USD 941.0 Million by 2021 from USD 528.0 Million in 2016, at a CAGR of 12.3% from 2016 to 2021. Growth in the pharmaceutical and biotechnology industries, increase in the number of new drug launches, and increasing R&D in life science research are the key factors driving the growth of this market. The market is further driven by factors such as increasing government support for pharmaceutical and biotechnology industries. On the other hand, the high degree of market consolidation is a major factor restraining the growth of this market.

On the basis of product, the sterility testing market is segmented into kits and reagents, instruments, and services. The kits and reagents segment is expected to account for the largest share of the market. The large share of the kits and reagents segment can be attributed to the requirement of the repeat purchase of these products, coupled with the increasing preference for kit-based testing.

On the basis of test, the sterility testing market is segmented into membrane filtration, direct inoculation, and other sterility tests. In 2016, the membrane filtration segment accounted for the largest share. The large share of this segment can primarily be attributed to rapid growth in the pharmaceutical and biotechnology end-use industry.

On the basis of application, the sterility testing market is segmented into pharmaceutical and biological manufacturing, medical devices manufacturing, and others applications. In 2016, the pharmaceutical and biological manufacturing segment is expected to account for the largest share primarily due to the rapid growth in the pharma and biotech industries.

On the basis of region, the global sterility testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The Asian market will witness the highest growth during the forecast period, primarily due to the increasing expenditure on life science research in the region and growing trend of pharmaceutical outsourcing to Asian countries like India and China.

Some of the major players operating in the sterility testing market are Merck KGaA (Germany), Charles River Laboratories International, Inc. (U.S.), bioMérieux SA (France), SGS S.A. (Switzerland), Sartorius AG (Germany), WuXi AppTec (China), and Thermo Fisher Scientific, Inc. (U.S.).

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る